Australia converts juveniles in recent countries by restricting AstraZeneca’s use of coronavirus, recommending that it not be administered to people under 50 years of age.
The announcement is being made that drug regulators will hold a series of urgent meetings on the day. It follows the advertisement of the European Medicines Agency that it has an angle between the vaccine and the coagulum.
Australian Prime Minister Scott Morrison said he had received a series of recommendations from a group assessing juveniles by night and that the principal of those whom Pfizer’s caretaker had been adopted now would be preferable to people under 50 years of age.
Morrison says that the recommendations were made by abundance of cautious debit to the rare secondary effect, but only that it was associated mostly with more young people.
“We have always had the necessary precautions based on the best possible medical advice,” he said.
The Australia Immunization Technical Assessment Group also recommends that people under the age of 50 who receive their first dose of AstraZeneca Debera vaccine proceed with the second, then the Indian medical recommendations that the rare coagulation.
The group says that only when the benefit is clear is the mayor that the risk should be to administer the initial dose of AstraZeneca to a person less than 50 years old.
The 50-year-old health workers who received the AstraZeneca vaccine will now have priority for Pfizer, which will certainly delay the process.